Deals channel feed

Bris­tol My­ers pays $100M up­front to col­lab­o­rate with Leqem­bi orig­i­na­tor in Alzheimer's

5 months ago

Sang­amo strikes an­oth­er brain-tar­get­ing AAV part­ner­ship, this time with Astel­las

5 months ago
Cell/Gene Tx

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

5 months ago
China
Pharma

No­var­tis turns to BioAge for new tar­gets based on longevi­ty and ex­er­cise

5 months ago
Pharma

No­vo Nordisk part­ners with Broad In­sti­tute spin­out Pho­tys af­ter the star­tup's lay­offs

5 months ago

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

5 months ago
Pharma

Bris­tol My­ers drops cell ther­a­py pacts with Im­mat­ics, Cen­tu­ry as part of port­fo­lio re­view

5 months ago
R&D
Cell/Gene Tx

FTC OKs No­vo-Catal­ent deal in ma­jor win for No­vo Nordisk’s GLP-1 man­u­fac­tur­ing

5 months ago
Manufacturing

BeiGene li­cens­es sol­id tu­mor drug, match­es with Ideaya’s com­bo plans

5 months ago
R&D

Ab­b­Vie makes an­oth­er small I&I ac­qui­si­tion, buy­ing Nim­ble for $200M

5 months ago
Startups
Pharma

Pad­lock share­hold­ers sue Bris­tol My­ers over mile­stone dis­pute af­ter 2016 ac­qui­si­tion

5 months ago
Pharma
Law

The End­points 100: The biotech in­dus­try braces for Trump 2.0

5 months ago
Bioregnum
R&D

Chro­ma, Nvel­op merge to form nChro­ma Bio, rais­ing $75M to en­ter the clin­ic

5 months ago
Financing
Cell/Gene Tx

Bay­er ex­its Eu­rope pact with Moberg for nail fun­gus drug af­ter Phase 3 fail

5 months ago
R&D

Wal­greens in talks to sell to pri­vate eq­ui­ty — re­port

5 months ago
Health Tech

Roche ini­tial­ly did­n't want to buy Po­sei­da — and part­ner Astel­las did­n't sub­mit an of­fer, new fil­ings show

5 months ago
Pharma

'It's the bi­ol­o­gy, stu­pid': Re­la­tion and GSK team up on fi­bro­sis, os­teoarthri­tis

5 months ago
Startups
AI

Eu­ro­pean Com­mis­sion green­lights $16.5B No­vo-Catal­ent ac­qui­si­tion 

5 months ago
FDA+
Manufacturing

Eli­av Barr de­fends Mer­ck­'s LaNo­va deal, but cau­tions VEGF bis­pecifics have yet to de­liv­er ma­ture da­ta

5 months ago
R&D

Gen­mab li­cens­es sec­ond mon­o­clon­al an­ti­body from Scan­cell

5 months ago

GSK's third new pact of the week fo­cus­es on Alzheimer's with start­up Mu­na Ther­a­peu­tics

5 months ago
Startups
Pharma

GSK ex­tends Shin­grix pact in Chi­na but for less mon­ey, adds RSV vac­cine deal

5 months ago
Pharma

No­vavax sells Czech fa­cil­i­ty to No­vo Nordisk for $200M to cut costs

5 months ago
Manufacturing

GSK part­ners with Rgen­ta on RNA-tar­get­ed small mol­e­cules for on­col­o­gy, oth­er ar­eas

5 months ago
Startups
Pharma
First page Previous page 567891011 Next page Last page
A service from the Financial Times